Gyapong John O, Twum-Danso Nana A Y
Trop Med Int Health. 2006 Feb;11(2):125-8. doi: 10.1111/j.1365-3156.2005.01542.x.
In 1997, the World Health Assembly resolved to eliminate lymphatic filariasis as a public health problem by the year 2020. By the end of 2004, almost half of the 83 endemic countries had initiated national programmes, providing mass drug administration to an at risk population of approximately 435 million. This remarkable achievement is the result of an enormous amount of technical, financial and political support from public and private sectors at the community, national, regional and global level. As the global programme to eliminate lymphatic filariasis enters its second quarter of operations, there are substantial opportunities to be taken and critical challenges to be addressed. These are the focus of this editorial.
1997年,世界卫生大会决定到2020年消除淋巴丝虫病这一公共卫生问题。到2004年底,在83个流行国家中,近半数已启动国家项目,为约4.35亿高危人群提供群体药物给药。这一非凡成就得益于社区、国家、区域和全球各级公共和私营部门大量的技术、财政和政治支持。随着全球消除淋巴丝虫病规划进入其业务开展的第二个阶段,有大量机遇可把握,也有重大挑战需应对。这些就是本社论的重点。